Research
A UAB study suggests that psychedelic drugs have a positive effect on antisocial, criminal behavior, warranting investigation of psychedelics as a crime reduction therapy.
This knowledge can provide targets in the search for novel bone-loss therapeutics to treat osteoporosis.
UAB researchers want to create new treatments for these banes of cardiovascular disease.
Researchers have discovered the mechanism of this control, with implications for developmental biology, the immune response and cancer dysregulation.
The August issue of the journal focused on genomics in rheumatic diseases, the complex effort to understand the genetic underpinnings of more than 100 diseases that affect joints and muscles.
Undergraduate research opportunity attracts students from across the United States.
This novel method improves purification of complex proteins by 10- to 500-fold, and it may aid both research and large-scale industrial production.
Hundreds of students will present academic pursuits in cutting-edge research topics.
The new study is the first to observe consolation in adult humans. The findings help correct the impression that humans are aggressive by nature and peaceful by culture.
This type of lab course is part of a national undergraduate biology education reform effort.
This is the first demonstration of donor microbes persisting in the recipient following fecal transplant, a finding made possible by a novel method to “fingerprint” individual strains of bacteria.
Michael Birrer, a leading medical oncologist at Harvard University, will take the reins as the new director of the UAB Comprehensive Cancer Center, succeeding the retiring Edward Partridge.
At a time when medical cannabis and cannabis-based products are gaining traction in the treatment of seizures, one of UAB’s CBD oil investigators serves as a guest editor for a special research journal devoted to cannabinoid research.
Allostery, a fundamental means of regulating enzymes, is crucial for living cells.
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
A UAB symposium on cardiovascular tissue engineering brought together some of the best in the business in this rapidly developing field of translational medicine.
The first target for the UAB spinoff Incysus Ltd. will be glioblastoma. Incysus has just received a European patent for its innovative approach to fighting cancer.
A new clinical trial seeks to determine whether a machine that pumps warm, oxygenated blood in cadaver kidneys can improve quality of the organ prior to transplant.
Class of 2017 option 2Chemistry and philosophy classes, a neuro-oncology lab, hospital volunteer work, and the TKE fraternity were all UAB steppingstones for the first-generation American and Florence High School graduate.
Mitochondrial DNA moving to the nucleus contributes to genomic instability in cancer cells, and a novel Fiber-FISH technique can rapidly map the mitochondrial DNA insertions in nuclear genomes.
Page 1 of 56
Back to Top